For example, following repeated administration of rAd-p53 injection, the expression of coxsackie-and-adenovirus receptors on the surface of tumor cells decreases, leading to a decrease in endocytosis of the p53 gene, thus leading to resistance. Here, TP53 is linked to neoplasm.